Results 41 to 50 of about 12,555 (213)
Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment
Медицинский совет, 2019 The article represents the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). It is noted that C. albicans causes candidiasis in 75-80% of cases.
N. A. Buralkina, O. V. Shabalova
doaj +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill +3 more
wiley +1 more source
The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
Медицинский совет, 2016 The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov +3 more
doaj +1 more source
Immunopathogenesis of recurrent vulvovaginal candidiasis [PDF]
Clinical Microbiology Reviews, 1996 Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic ...
P L, Fidel, J D, Sobel
openaire +3 more sources
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu +3 more
wiley +1 more source
Effective treatment for vulvovaginal candidiasis: case reports [PDF]
РМЖ. Мать и дитя, 2019 Effective treatment for vulvovaginal candidiasis: case reports A.L. Tikhomirov1, S.I. Sarsaniya2 1A.I. Evdokimov Moscow University of Medicine and Dentistry, Moscow, Russian Federation 2LLC “S-Mariya”, Moscow, Russian Federation Treatment ...
Tikhomirov A.L., Sarsaniya S.I.
doaj
Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis [PDF]
РМЖ. Мать и дитя, 2020 E.A. Markova Pirogov Russian National Research Medical University, Moscow, Russian Federation Recurrent vulvovaginal infections being an epidemiological and clinical issue also have social and psychological implications.
E.A. Markova
doaj
Preserving reproductive health before the first pregnancy
Репродуктивная эндокринология, 2022 Research objective: to evaluate the effectiveness of drugs based on decamethoxine for the treatment of inflammatory diseases of genital organs in adolescent girls entering reproductive age. Materials and methods. The study included 96 patients aged 17–19
О.V. Kravchenko
doaj +1 more source
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study
Journal of the European Academy of Dermatology and Venereology, EarlyView.In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai +11 more
wiley +1 more source
Sertaconazole in the treatment of vulvovaginal candidiasis
Медицинский совет, 2019 Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease.
Z. N. Efendieva
doaj +1 more source